| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/07/1994 | EP0613376A1 Use of igf-1 |
| 09/07/1994 | EP0613375A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 09/07/1994 | EP0478609B1 Srif-related peptides and uses thereof |
| 09/07/1994 | EP0457848B1 Treatment of ventilator dependency with growth hormone |
| 09/07/1994 | EP0411033B1 Storage stable formulations of homogenous dimeric m-csf |
| 09/07/1994 | CN1091775A Marmoset zona pellucida protein ZP3 |
| 09/07/1994 | CN1091746A Synthetic peptides derived from vitronectin and pharmaceutical compositions them |
| 09/07/1994 | CN1091634A Stabilized pharmaceutical compositions comprising an HMG-conreductase inhibitor compound |
| 09/07/1994 | CN1091583A Method for the production of proteins in plant fluids |
| 09/06/1994 | US5344990 Process for the preparation of a renin inhibiting compound |
| 09/06/1994 | US5344920 Method of separating glycosylated and non-glycosylated prolactin by ion exchange chromatography |
| 09/06/1994 | US5344919 Heterodimeric protein complex; pancreatic cancer diagnosis |
| 09/06/1994 | US5344918 Process for the manufacture of a high-purity activated factor VII concentrate essentially free of vitamin K-dependent factors and factors VIIIC and VIIICAg |
| 09/06/1994 | US5344915 Proteins and the preparation thereof |
| 09/06/1994 | US5344833 Oxepane isomers of rapamycin useful as immunosuppressive agents |
| 09/06/1994 | US5344832 Administering dopamine agonist and prolactin stimulator |
| 09/06/1994 | US5344822 Methods useful in endotoxin prophylaxis and therapy |
| 09/06/1994 | US5344820 Infection protectant |
| 09/06/1994 | US5344819 Pharmaceutical compositions for use in treating inflammation |
| 09/06/1994 | US5344783 Platelet aggregation inhibitors |
| 09/06/1994 | US5344773 Human uterine tissue plasminogen activator produced by recombinant DNA |
| 09/06/1994 | US5344764 Protein inhibitors of phospholipase A2 purified from inflammatory sites and production process |
| 09/06/1994 | US5344654 Protein coating |
| 09/06/1994 | US5344644 Cytokines or hematopoeitic factors and sulfate groups on mucopolysaccharides |
| 09/06/1994 | US5344393 Use of synthetic oxygen carriers to facilitate oxygen delivery |
| 09/06/1994 | CA2116280A1 Huntingtin dna, protein and uses thereof |
| 09/06/1994 | CA2114168A1 Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides |
| 09/01/1994 | WO1994019692A1 Alzheimer's disease therapeutics |
| 09/01/1994 | WO1994019493A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death |
| 09/01/1994 | WO1994019473A1 Modulators of gene expression |
| 09/01/1994 | WO1994019470A1 Soluble t-cell receptor alpha chain and derivatives used as prophylactic and therapeutic agents for autoimmune diseases |
| 09/01/1994 | WO1994019466A2 A novel family of anti-carcinoembryonic antigen chimeric antibodies |
| 09/01/1994 | WO1994019465A2 NOVEL DNA- BINDING REGULATOR OF c-myc EXPRESSION WHICH BINDS TO THE FAR UPSTREAM ELEMENTS (FUSE) AND cDNA THEREFOR |
| 09/01/1994 | WO1994019463A2 Developmental tyrosine kinases and their ligands |
| 09/01/1994 | WO1994019462A1 Harp family growth factors, preparation methods therefor and uses thereof |
| 09/01/1994 | WO1994019457A1 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody |
| 09/01/1994 | WO1994019456A1 Vpr function and activity |
| 09/01/1994 | WO1994019455A1 In vitro maturation of oocytes with inhibin, activin or inhibin/activin combinations |
| 09/01/1994 | WO1994019375A1 Iron-lactoferrin combination and process for producing the same |
| 09/01/1994 | WO1994019374A1 IgM-SPECIFIC RECOMBINANT RHEUMATOID ARTHRITIS ANTIGEN |
| 09/01/1994 | WO1994019373A1 Metal-interferon-alpha crystals |
| 09/01/1994 | WO1994019372A1 Cyclic bradykinin antagonist peptides |
| 09/01/1994 | WO1994019370A1 Gnrh antagonists |
| 09/01/1994 | WO1994019369A1 Treatment of cancerous growths with biologically active peptides and protease inhibitors |
| 09/01/1994 | WO1994019368A1 Novel endothelin antagonist |
| 09/01/1994 | WO1994019367A1 Spiro piperidines and homologs promote release of growth hormone |
| 09/01/1994 | WO1994019325A1 Coupling product obtained from hystamine and an amino acid |
| 09/01/1994 | WO1994019023A1 Cyclobutyl antisense oligonucleotides, methods of making and use thereof |
| 09/01/1994 | WO1994019022A1 Composition for use in the treatment of tumours and the immunization of humans and animals |
| 09/01/1994 | WO1994019021A1 Protein conjugates, compositions containing them and their applications as medicament |
| 09/01/1994 | WO1994019020A1 Excipient stabilization of polypeptides treated with organic solvents |
| 09/01/1994 | WO1994019017A1 Synergistic composition of cd4-based protein and anti-hiv-1 antibody, and methods of using same |
| 09/01/1994 | WO1994019016A1 Inhibition of intimal hyperplasia using antibodies to pdgf receptors |
| 09/01/1994 | WO1994019011A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 09/01/1994 | WO1994019009A1 Methods for modifying the t cell repertoire of the immune system |
| 09/01/1994 | WO1994019008A1 Combinations of retroviral inhibitors |
| 09/01/1994 | WO1994019007A1 Ribosome inactivating protein compositions having reduced antigenicity |
| 09/01/1994 | WO1994019006A1 Remedy for cystic fibrosis |
| 09/01/1994 | WO1994019005A1 Enzyme-containing pharmaceutical or cosmetic composition, process for preparing the same and its use |
| 09/01/1994 | WO1994019004A1 Ligand antagonists for treatment of breast cancer |
| 09/01/1994 | WO1994019003A1 Microemulsions comprising therapeutic peptides |
| 09/01/1994 | WO1994019002A1 Regulator regions of g proteins |
| 09/01/1994 | WO1994019001A1 Microemulsions comprising therapeutic peptides |
| 09/01/1994 | WO1994019000A1 Microemulsions containing pharmaceutical compositions |
| 09/01/1994 | WO1994018999A1 A mutant protein and methods and materials for making and using it |
| 09/01/1994 | WO1994018998A1 Treatment of allergic responses using mhc-peptide complexes |
| 09/01/1994 | WO1994018996A1 Method for administering growth hormone releasing peptides |
| 09/01/1994 | WO1994018991A1 EXPANSION OF STEM CELLS IN LONG TERM BONE MARROW CULTURES BY NEUTRALIZATION OF TGF-$g(b) |
| 09/01/1994 | WO1994018986A1 Use of oligosaccharide glycosides as inhibitors of bacterial adherence |
| 09/01/1994 | WO1994018981A1 Fibrinogen receptor antagonists |
| 09/01/1994 | WO1994018947A1 High purity protamine-dna complex and use of same |
| 09/01/1994 | WO1994018832A1 Cd4 mediated modulation of lipid kinases |
| 09/01/1994 | WO1994016069A3 Ras associated gap proteins |
| 09/01/1994 | WO1994015637A3 Prevention of suppression of immune defense against cancer caused by the cancer-associated scm-recognition peptides |
| 09/01/1994 | WO1994015587A3 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 09/01/1994 | WO1994012638A3 Interleukin-3 (il-3) multiple mutation polypeptides |
| 09/01/1994 | WO1994010194A3 Molecule fragments (peptides) of the main allergens contained in the pollen of trees of the fagales order |
| 09/01/1994 | WO1994006449A3 Morphogen-induced liver regeneration |
| 09/01/1994 | WO1994006447A3 60a protein-induced morphogenesis |
| 09/01/1994 | WO1994006420A3 Morphogen treatment of gastrointestinal ulcers |
| 09/01/1994 | WO1993012756A3 Transfection of lung via aerosolized transgene delivery |
| 09/01/1994 | CA2594184A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 09/01/1994 | CA2168019A1 Igm-specific recombinant rheumatoid arthritis antigen |
| 09/01/1994 | CA2157049A1 Use of oligosaccharide glycosides as inhibitors of bacterial adherence |
| 09/01/1994 | CA2157041A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death |
| 09/01/1994 | CA2156921A1 Metal-interferon-alpha crystals |
| 09/01/1994 | CA2156850A1 Harp family growing factors, preparation methods and uses thereof |
| 09/01/1994 | CA2156635A1 Composition useful for the treatment of tumors and immunization of organisms against tumors |
| 09/01/1994 | CA2156421A1 Synergistic composition of cd4-based protein and anti-hiv-1 antibody, and methods of using same |
| 09/01/1994 | CA2156395A1 Regulator regions of g proteins |
| 09/01/1994 | CA2155953A1 Protein conjugates, compositions containing them and their applications as medicament |
| 09/01/1994 | CA2155934A1 A novel family of anti-carcinoembryonic antigen chimeric antibodies |
| 09/01/1994 | CA2155515A1 Expansion of stem cells in long term bone marrow cultures by neutralization of tgf-.beta. |
| 09/01/1994 | CA2155123A1 Fibrinogen receptor antagonists |
| 08/31/1994 | EP0613006A1 Antibodies to cachectin and immunoassays |
| 08/31/1994 | EP0612846A1 G-CSF analog compositions and methods |
| 08/31/1994 | EP0612845A2 Purified opioid receptor |
| 08/31/1994 | EP0612844A2 Expression constructs containing HIV inhibitory antisense and other nucleotide sequences, retroviral vectors and recombinant retroviruses containing same |
| 08/31/1994 | EP0612763A1 Cyclic derivatives of angiopeptin, their preparation and their pharmaceutical compositions |
| 08/31/1994 | EP0612762A1 Elucidation and synthesis of selected pentapeptides |